Non-Alcoholic Fatty Liver Disease is a growing concern. It affects a large portion of the global population. The disease ...

Casualty has been pulled from the BBC One schedule on Saturday night as the channel's usual line-up is replaced ...

Cancer treatment has long faced a challenging trade-off: therapies strong enough to eliminate tumors often cause severe side effects. One promising solution involves cytokines, natural proteins that ...

Can research into a rare, accelerated aging disease and "zombie cells" teach us something about the normal aging process?

"Regeneron nabs dosing edge with Lynozyfic’s FDA approval in multiple myeloma" was originally created and published by ...

Farnesoid X receptor (FXR) has become a particularly attractive target for the discovery of drugs for the treatment of liver and metabolic diseases. Obeticholic acid (INT-747), a FXR agonist, has ...

Personal tragedy led Doug Evans, founder of Exton-based Kensey Nash, to change his business trajectory and become CEO of ...

Increasing access to ADHD diagnosis and medication is a good move. But it shouldn’t be the whole plan to address a condition ...

Recently, there has been a significant development on the horizon in the field of liver disease research. Scientists have identified a potential new treatment that holds the potential to transform the ...

Riverbend Water Resources District is preparing to acquire land for building a $498 million regional water treatment plant at ...

The study is intended to focus on diagnostics and treatment of Lyme IACI symptoms and not to improve diagnostics and treatment for acute Lyme disease. As such, the prevention of Lyme disease ...

The non-alcoholic steatohepatitis (NASH) clinical trials market is estimated to generate a market size of USD 2.96 billion in ...